Sagent Pharmaceuticals Inc recalls Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcuta…

Recall date

February 28, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0435-2023

FDA classification

Class II

Brand / firm

Sagent Pharmaceuticals Inc

Sold / distributed

USA Nationwide

Why it was recalled

Labeling: Not elsewhere classified

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01